Research and Markets has announced the addition of the "Diabetes
Insipidus - Global API Manufacturers, Marketed and Phase III Drugs
Landscape, 2017" drug pipelines to their offering.
Diabetes Insipidus - Global API Manufacturers, Marketed and Phase III
Drugs Landscape, 2017, provides comprehensive insights about the
marketed drugs, drug sales, Phase III pipeline drugs and their API
Manufacturers across the globe.
A key objective of the Diabetes Insipidus Report is to understand the
market and pipeline status of the drugs around Diabetes Insipidus to
explore the generic development opportunities, licensing opportunities
and to gain competitive advantage on designing pipeline strategies. The
Report provides the historical and forecasted sales of the drugs till
The Diabetes Insipidus Report gives insights into patents, providing the
patent protection data and marketing exclusivity of all the drugs across
the Diabetes Insipidus.
While the leading brands, companies and chemicals are considered
thoroughly, the report also provides details on the Global API
Manufacturers across the globe, covering Drug Master Filings of US,
Europe and API Manufacturers in Asia, specifically China and India.
Key Topics Covered:
1. Indication Overview
2. Market Drugs Landscape
3. Global API Manufacturers Assessment
4. Phase III Drugs Landscape
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Diabetes Insipidus
7. Phase III Drugs for Diabetes Insipidus
8. Discontinued Drugs for Diabetes Insipidus
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/w2xts8/diabetes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170217005603/en/
[ Back To NFVZone's Homepage ]